Evidence map›Paper›PMID 33031963›Full record

GuidelineGynecologie, obstetrique, fertilite & senologie2020

[Infection with SARS-CoV-2 in pregnancy. Update of Information and proposed care. CNGOF].

V Peyronnet, J Sibiude, C Huissoud, F-X Lescure, J-C Lucet, L Mandelbrot, I Nisand, J Belaish-Allart, C Vayssière, Y Yazpandanah and 2 more

Open access · greenAbstract readPractice GuidelineReview
In one paragraph

Guideline in Gynecologie, obstetrique, fertilite & senologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Factors associated with SARS-CoV-2 transplacental transmission.American journal of obstetrics and gynecology · 2022
    Article
  5. Article
  6. Impact of COVID-19 infection in pregnancy and neonates: A case control study.Journal of gynecology obstetrics and human reproduction · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

V PeyronnetService de gynécologie-obstétrique, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France.
J SibiudeService de gynécologie-obstétrique, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France.
C HuissoudUniversity Lyon, University Claude Bernard, 69000 Lyon, France; Hôpital de la Croix-Rousse, hospices civils de Lyon, 69004 Lyon, France; Inserm U846, stem cell and brain research institute, 18, avenue Doyen-Lepine, 69500 Bron, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France.
F-X LescureInserm IAME-U1137, 75000 Paris, France; Service de maladies infectieuses et tropicales, hôpital Bichat Claude-Bernard, université de Paris, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France.
J-C LucetInserm IAME-U1137, 75000 Paris, France.
L MandelbrotService de gynécologie-obstétrique, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France.
I NisandCNGOF, 91, boulevard de Sébastopol, 75002 Paris, France.
J Belaish-AllartCNGOF, 91, boulevard de Sébastopol, 75002 Paris, France.
C VayssièreHôpital Paule-de-Viguier, CHU de Toulouse, 31000 Toulouse, France; Inserm UMR1027, équipe SPHERE, université Toulouse III, 31000 Toulouse, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France.
Y YazpandanahInserm IAME-U1137, 75000 Paris, France; Service de maladies infectieuses et tropicales, hôpital Bichat Claude-Bernard, université de Paris, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France.
D LutonFHU Prematurity Inserm U1016, service de gynécologie obstétrique, maternité Aline de Crepy, hôpital Bichat, institut IMAGINE, université de Paris, AP-HP, 75018 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France.
O PiconeService de gynécologie-obstétrique, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France. Electronic address: olivier.picone@aphp.fr.
Inserm · FRHôpital Bichat-Claude-Bernard · FRHôpital Louis-Mourier · FRUniversité Claude Bernard Lyon 1 · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe coronavirus SARS-CoV-2 identified late 2019 in China had spread across all continents. In the majority of cases, patients have mild symptoms (fever, cough, myalgia, headache, some digestive disorders) or are asymptomatic, however it can cause serious lung diseases and lead to death. On September 2020, over 28 million people have been infected with over 920,000 deaths.

methodsIn view of the evolution of the epidemic the French National College of Obstetricians and Gynecologists has decided to update the recommendations previously issued. To do this, the same group of experts was called upon to carry out a review of the literature and take into account the opinions of the General Directorate of Health (DGS), the "Haute Autorité de Santé" (HAS) and the "Haut Conseil de santé Publique" (HCSP).

resultsThe data on consequences during pregnancy have accumulated. The symptoms in pregnant women appear to be similar to those of the general population, but an increased risk of respiratory distress exists in pregnant women especially in the third trimester. A case of intrauterine maternal-fetal transmission has been clearly identified. Induced prematurity and cases of respiratory distress in newborns of infected mothers have been described.

conclusionIn light of the new data, we propose updated recommendations. These proposals may continue to evolve in view of the pandemic and of advances in studies in pregnant women.

Indexed as

BetacoronavirusSymptom AssessmentCoronavirus InfectionsCOVID-19FemaleFranceHumansMalePandemicsPneumonia, ViralPregnancyPregnancy Complications, InfectiousPregnancy Trimester, ThirdSARS-CoV-2Coronavirus SARS-CoV-2Covid-19COVID-19GrossesseMaternal-fetal transmissionNewbornNouveau-néPregnancyTransmission materno-fœtale

Identifiers

PMID33031963
PMCPMC7534662
OpenAlexW3092218316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.